Presentation of Donesta® Phase 3 Topline Efficacy Results at the 20th ISGE World Congress

Liege, Belgium, 12 May 2022 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, announces that several presentations focusing on therapeutic opportunities for estetrol (E4) will be held at the 20th World Congress of the International Society of Gynecological Endocrinology (ISGE) taking place from 11-14 May 2022 in Florence, Italy. A selection of these presentations will be made available in the coming days in the investors section of the company’s website.